Dawn J. Swan
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Toxicity Under-Reporting in Early-Phase Plasma Cell Dyscrasia Clinical Trial Abstracts.
Journal: JCO oncology practice
Published: May 29, 2026
Coagulopathy in acute promyelocytic leukaemia: Can we better predict and prevent catastrophic bleeding?
Journal: Thrombosis research
Published: March 17, 2026
Thrombosis after surgical splenectomy - why, in whom and can we prevent it?
Journal: Thrombosis research
Published: February 01, 2026
How to Safely Anticoagulate Patients With Renal Impairment.
Journal: British journal of hospital medicine (London, England : 2005)
Published: January 06, 2026
Corrigendum: Bleeding in Patients with Renal Impairment: A Current Perspective.
Journal: Seminars in thrombosis and hemostasis
Published: December 09, 2025
The dilemma of thromboprophylaxis in stroke patients.
Journal: Clinical medicine (London, England)
Published: November 22, 2025
Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity.
Journal: International immunopharmacology
Published: November 18, 2025
Bleeding in Patients with Renal Impairment: A Current Perspective.
Journal: Seminars in thrombosis and hemostasis
Published: October 27, 2025
In a nutshell: Testing DOAC levels-when, why and what it means?
Journal: British journal of haematology
Published: October 06, 2025
Von Willebrand disease: more than just a bleeding disorder.
Journal: Research and practice in thrombosis and haemostasis
Published: September 05, 2025
Myeloma bone disease: A constant problem in the changing landscape of myeloma management.
Journal: British journal of haematology
Published: August 19, 2025
Last Updated: 09/26/2026